Our Company / Research&Innovation / Externally Sponsored Research

Externally Sponsored Research

At Alfasigma, innovation is at the heart of everything we do. We are committed to advancing science and improving lives through bold ideas, cutting-edge technologies, and meaningful partnerships. We proudly support investigator-sponsored studies and welcome opportunities for collaborative research that push boundaries and explore new frontiers. Together, we can shape the future of healthcare and discovery.

We actively support unsolicited requests for investigator-sponsored studies and collaborative research initiatives that align with our vision to accelerate therapeutic breakthroughs in some specific area of interest.

Investigator Sponsored Research (ISR) is initiated,designed, and led by independent researchers. For an ISR project, an investigator or institution outside of Alfasigma is the study sponsor. Alfasigma's involvement in an ISR project is solely providing funding and/or supplying th study drug.

Sponsored Collaborative Research (SCR) is similar to ISR where the study sponsor is an investigator or institution outside of Alfasigma. However, beyond providing funding and /or study drug, in a SCR, Alfasigma is also involved in some aspects of the research such as involvement in study design, protocol development/review, conduct of study, providing data/biological samples, data/sample analysis and/or publication preparation/authorship.

To submit an application for any externally sponsored research, visit our online proposal submission portal: iEnvision.

Your request will be reviewed by our cross-functional committee that may suggest improving the scientific merit of the proposal and enhance consistency with Alfasigma's approval criteria. However, the study sponsor, the principal investigator, will have full and final discretion and responsibility for all aspects of the study design, implementation, data analysis, and data dissemination, including compliance with all laws and regulations applicable to research sponsors.

The terms under which Alfasigma will provide support to any approved proposal will be described in a signed contract.

Read More

Supporting existing assets and developing new indications to address unmet needs is our Research & Development Department focus.

Social contract between the company and internal and external stakeholders having a normative value for the entire Alfasigma system.
Reporting an adverse event is important in order to safeguard the patients who are taking it and ensure a favourable benefit-risk balance for the population.
×

You’re entering Alfasigma global website

I agree